India Pesticides Reports Strong Q2 FY26 Results; Revenue Up 26% and Approves New Capex
India Pesticides reported strong Q2 FY26 consolidated results with revenue up 26% to ₹295 crore and PAT up 22% to ₹32 crore. The company commissioned expanded capacity and approved a ₹65 crore backward integration project.
Strong financial performance with double-digit growth in key metrics, coupled with strategic capacity expansion and a new backward integration project, is likely to have a significant positive impact on the company's future operations and stock performance.
The company reported significant year-on-year growth in revenue, EBITDA, and PAT for both Q2 and H1 FY26. Export sales nearly doubled, and new capacity expansion and a backward integration project were approved, indicating future growth prospects.
* India Pesticides Limited (IPL) announced its unaudited financial results for the quarter and half year ended 30th September 2025, along with an investor presentation. * Q2 FY2026 Consolidated Performance Highlights: * Total Revenue increased by 26.0% year-on-year (YoY) to ₹295 crore, driven by 22% volume growth and strong demand recovery in key export markets. * Export sales nearly doubled to ₹140 crore from ₹74 crore in Q2 FY25. * Domestic revenue marginally declined to ₹150 crore due to delayed monsoon. * EBITDA grew by 37.6% YoY to ₹54 crore, with margins improving to 18.3%. * Gross Profit increased to ₹132 crore, and Profit After Tax (PAT) grew by 22.0% YoY to ₹32 crore. * H1 FY2026 Consolidated Performance Highlights: * Total Revenue was ₹579 crore, up 26.4% YoY. * EBITDA stood at ₹108 crore, up 52.1% YoY, with margins at 18.6%. * PAT was ₹67 crore, a 46.6% YoY increase. * Operational Developments: * The expanded formulation facility was commissioned, increasing capacity from 6,500 MT to 10,000 MT per annum, with an investment of ₹2.8 crore funded through internal accruals. * The Board approved a new backward integration project at Sandila for 26 DEA, a key input for herbicides, with a proposed capacity of 4,000 MT and an investment of ₹65 crore. * The company has a budgeted Capex of ₹116 crore for FY26. * Financial Position: * Cash & Bank Balance including long-term deposit was ₹120 crore as of 30th September 2025. * Net cash position improved to ₹79 crore. * Total debt decreased from ₹52 crore in FY25 to ₹41 crore in H1 FY26, with a low debt-to-equity ratio of 0.03x. * Management Outlook: Anand Swarup Agarwal, Founder, Promoter and Director, expressed confidence in sustaining growth trajectory, supported by consistent export demand, gradual domestic market recovery, and benefits from capacity expansion. * Sustainability: IPL continues its CSR and sustainability initiatives, contributing to education, community welfare, and environmental sustainability.
What to do with a filing like this
India Pesticides Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Pesticides Limited. Read the original for the full detail.